International Isotopes Inc.

Equities

INIS

US45972C1027

Industrial Machinery & Equipment

Market Closed - OTC Markets Other stock markets 09:13:40 24/05/2024 pm IST			5-day change	1st Jan Change
0.039 ^USD	+8.18%		+6.27%	-2.50%

15/05	International Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
11/04	An unknown buyer has entered into an Asset Purchase Agreement to acquire Unused assets in FEP business of International Isotopes Inc for $12.5 million.	CI

International Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

November 15, 2022 at 01:54 am IST

International Isotopes Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 0.568669 million compared to USD 0.136869 million a year ago.
For the nine months, net income was USD 0.414328 million compared to net loss of USD 0.919408 million a year ago.

Latest news about International Isotopes Inc.

International Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
An unknown buyer has entered into an Asset Purchase Agreement to acquire Unused assets in FEP business of International Isotopes Inc for $12.5 million.	11/04	CI
International Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
International Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
International Isotopes Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	12/23/12	CI
International Isotopes Inc. Announces Executive Changes	18/23/18	CI
International Isotopes Inc. Appoints Shahe Bagerdjian to Serve as a Member of the Board	18/23/18	CI
International Isotopes Inc. acquired Nuclear lung ventilation product line from Amici Inc.	21/23/21	CI
Earnings Flash (INIS) INTERNATIONAL ISOTOPES Reports Q1 EPS $0.00	16/23/16	MT
International Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
International Isotopes Inc. Announces Shahe Bagerdjian Appointed as President of the Company, Effective Immediately	08/23/08	CI
International Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	06/23/06	CI
International Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
International Isotopes Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Tranche Update on International Isotopes Inc.'s Equity Buyback Plan announced on January 26, 2021.	17/22/17	CI
International Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	17/22/17	CI
Tranche Update on International Isotopes Inc.'s Equity Buyback Plan announced on January 26, 2021.	01/22/01	CI
International Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
Pharmalogic Idaho, LLC completed the acquisition of Certain Assets of International Isotopes Inc. from International Isotopes Inc..	18/22/18	CI
Pharmalogic Idaho, LLC entered into an Asset Purchase Agreement to acquire Certain Assets of International Isotopes Inc. from International Isotopes Inc. for $4 million.	16/22/16	CI
International Isotopes Inc.'s Equity Buyback announced on January 26, 2021 has expired.	25/22/25	CI
International Isotopes Inc. Announces Exclusive Licensing Agreement for Commercialization of Radiolabled Antibody Test for Detecting SARS CoV-2	07/21/07	CI
Tranche Update on International Isotopes Inc.'s Equity Buyback Plan announced on January 26, 2021.	13/21/13	CI
International Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	13/21/13	CI
Tranche Update on International Isotopes Inc.'s Equity Buyback Plan announced on January 26, 2021.	17/21/17	CI

Chart International Isotopes Inc.

Duration

Period

More charts

Company Profile

International Isotopes Inc. manufactures a range of nuclear medicine calibration and reference standards. Its Theranostics Products Segment includes production and distribution of Iodine-131 generic drug products and various isotopically pure radiochemicals. Its Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources. Its Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Its Fluorine Products segment is involved in the production of small-scale qualification samples of purity fluoride gas for various industrial applications, and development of laboratory and analytical processes.

Sector

Industrial Machinery & Equipment

Calendar

14/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Testing & Measuring Equipment

	1st Jan change	Capi.
INTERNATIONAL ISOTOPES INC.	-2.50%	2.04Cr
SMC CORPORATION	+6.19%	3.34TCr
MKS INSTRUMENTS, INC.	+27.35%	880.34Cr
COGNEX CORPORATION	+14.21%	819.07Cr
BADGER METER, INC.	+29.97%	589.76Cr
INFICON HOLDING AG	+20.56%	388.85Cr
WUHAN GUIDE INFRARED CO., LTD.	-11.10%	382.61Cr
RENISHAW PLC	+13.61%	377.61Cr
HORIBA, LTD.	+18.45%	351.8Cr
ESCO TECHNOLOGIES INC.	-6.16%	282.8Cr

Testing & Measuring Equipment